A detailed history of Smartleaf Asset Management LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Smartleaf Asset Management LLC holds 322 shares of EXAS stock, worth $19,864. This represents 0.0% of its overall portfolio holdings.

Number of Shares
322
Previous 77 318.18%
Holding current value
$19,864
Previous $3.43 Million 520.12%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$42.43 - $70.83 $10,395 - $17,353
245 Added 318.18%
322 $21.2 Million
Q2 2024

Aug 13, 2024

BUY
$41.33 - $74.26 $3,182 - $5,718
77 New
77 $3.43 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.9B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Smartleaf Asset Management LLC Portfolio

Follow Smartleaf Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smartleaf Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Smartleaf Asset Management LLC with notifications on news.